loader2
Partner With Us NRI

Wanbury Ltd share Price Today

Company details

153.37
161.99
46.60
179.35
6M Return 18.53%
1Y Return 180.94%
Mkt Cap.(Cr) 508.27
Volume 127,403
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 127,403

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Wanbury Ltd shares SWOT Analysis

Strengths (10)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Strong Annual EPS Growth

Weakness (4)

  • MACD Crossover Below Signal Line
  • Companies with High Debt
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • Stock with Low PE (PE < = 10)

Threats (2)

  • Companies Increasing Debt as per Annual Report
  • Increasing Trend in Non-Core Income

Resistance and support

R1 160.4
R2 165.5
R3 169.0
Pivot

156.86

S1 151.7
S2 148.2
S3 143.1
EMA SMA
156.0
152.8
146.5
129.0
154.2
151.7
152.5
127.5
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SURBHI INVESTMENTS AND TRADING COMPANY PRIVATE LIMITED Bulk Purchase 2024-05-27 148 562399 NSE
VIJAY KUNDANMAL CHORARIA Bulk Sell 2024-05-27 148 599000 NSE
ELIZABETH MATHEW Bulk Sell 2024-01-09 133.04 190000 NSE
Name Category Shares
EXPERT CHEMICALS (INDIA) PVT LTD PROMOTER 30.56%
KINGSBURY INVESTMENTS INC. PROMOTER 9.23%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Wanbury Ltd Stocks COMPARISON

Financials( in Cr) Wanbury Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Zydus Lifesciences Ltd
Price 155.22 1,520.85 4,596.45 1,480.80 1,073.95
% Change -0.70 0.30 1.64 -0.01 1.60
Mcap Cr 508.27 364,902.86 122,021.50 119,554.91 108,064.50
Revenue TTM Cr 499.65 43,885.68 7,767.51 15,790.60 17,237.40
Net Profit TTM Cr -10.40 8,560.84 1,823.38 2,513.47 1,997.30
PE TTM 16.67 36.50 76.24 28.08 28.04
1 Year Return 180.94 48.84 27.62 46.72 84.38
ROCE 0.00 16.79 19.30 14.76 16.25
ROE 0.00 16.46 14.89 10.66 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: -32.81 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 29,542.69 26,564.54
LAST 3M 107,300.08 -872.81
LAST 6M 187,950.75 839.71
LAST 12M 304,454.24 86,051.23
Wanbury avails term loan of Rs 60 cr from Tata Capital

Jun 28, 2024 l BSE Announcement

Wanbury Limited - Press Release

Jun 27, 2024 l NSE Announcement

Wanbury Limited - Loss of Share Certificates

Jun 26, 2024 l NSE Announcement

Date Action Type Ratio
No data found

Wanbury Ltd Information

Stock PE (TTM)
16.67
Promoter Holding
39.79%
Book Value
8.4983
ROCE
0%
ROE
0%
Description
  • Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Hon`ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively. The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008. The novel product `Cdense Gems` was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, Myotol-F, targeted at female infertility in 2013, it launched Folinine. The Company`s newly launched products Myotol-F (to treat polycystic ovarian syndrome) and Cal-K2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.

Registered Address

BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703

Tel : 91-22-67942222
Email : shares:wanbury.com; jitendra.gandhi:wanbury.com
Website : http://www.wanbury.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524212
NSE Code : WANBURY
Book Closure Date (Month) : Sep
BSE Group : T
ISIN : INE107F01022

FAQ’s on Wanbury Ltd Shares

You can buy Wanbury Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Wanbury Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 28, 2024 03:56 PM the closing price of Wanbury Ltd was Rs.155.22.

The latest PE ratio of Wanbury Ltd as of Jun 28, 2024 03:56 PM is 16.67

The latest PB ratio of Wanbury Ltd as of Jun 28, 2024 03:56 PM is 0.05

The 52-week high of Wanbury Ltd share price is Rs. 179.35 while the 52-week low is Rs. 46.60

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 28, 2024 03:56 PM, the market cap of Wanbury Ltd stood at Rs. 508.27 Cr.

Download App

Download Our App

Play Store App Store
market app